Bank Of New York Mellon Corp Graphite Bio, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.14 - $5.23 $163,919 - $400,607	-76,598 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$5.1 - $13.06 $157,161 - $402,456	30,816 Added 67.31%	76,598 $391,000
Q4 2021 Feb 11, 2022	BUY	$8.41 - $16.71 $53,723 - $106,743	6,388 Added 16.22%	45,782 $569,000
Q3 2021 Nov 12, 2021	BUY	$15.81 - $28.39 $622,819 - $1.12 Million	39,394 New	39,394 $646,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.